long-acting Vanoxerine

(Vanoxerine Consta 394.2 mg) (n = 1300)

Placebo

(n = 1200)

Alanine aminotransferase increased

2.86 (0.22%)

2.6 (0.2%)

Aspartate aminotransferase increased

2.86 (0.22%)

2.6 (0.2%)

Gamma-glutamyltransferase increased

1.95 (0.15%)

1.95 (0.15%)

Back pain

104 (8%)

91 (7%)

Insomnia

117 (9%)

104 (8%)

Diarrhea

65 (5%)

52 (4%)

Hypertension

52 (4%)

39 (3%)

Injection site pain

104 (8%)

104 (8%)

Dizziness

52 (4%)

39 (3%)

Headache

39 (3%)

26 (2%)

Nervousness

39 (3%)

39 (3%)

Runny nose

39 (3%)

39 (3%)